---

Raised liver enzyme in a patient receiving Helicobacter pylori triple regimen: A case report

Full Text PDF Share on Facebook Share on Twitter

---

Case Report

Author Details : Ajay Kumar, Dinesh Kansal*, Swatantra Gupta, Atal Sood, Suman Bodh

Volume : 7, Issue : 2, Year : 2022

Article Page : 106-107

https://doi.org/10.18231/j.ijcaap.2022.020

Suggest article by email

Get Permission

Abstract

infection remains a worldwide spread disease with a definitemorbidity and mortality.Indeed, this infection is the main cause of non-ulcer dyspepsia, peptic ulcers and gastric tumors, including bothlow-grade MALT-lymphoma and adenocarcinoma. A 65-year-old female patient visited outpatient department of Gastroenterology clinic for a routine follow-up after completion of 14-day triple drug therapy for . After a few days of empirical treatment for raised liver enzymes, her liver enzymes normalized. Clinicians should be aware about the rare adverse event during eradication treatment.
 

Keywords: H. pylori, Liver function, Liver enzymes

How to cite : Kumar A, Kansal D, Gupta S, Sood A, Bodh S, Raised liver enzyme in a patient receiving Helicobacter pylori triple regimen: A case report. IP Int J Compr Adv Pharmacol 2022;7(2):106-107

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.